A Prospective Clinical Study to Evaluate the Safety and Effectiveness of Pulmonary Vein Isolation Plus Box Isolation of Fibrotic Areas With the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 115 participants.
Also called NCT06973031
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 115 participants
- Sponsor
- Registry
-
NCT06973031
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Germany
- Registry status
- Recruiting
Technical summary
Registry record NCT06973031. Allocation not applicable; no masking; primary purpose treatment. Start 2025-06-10 (actual); primary completion 2028-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Prospective Clinical Study to Evaluate the Safety and Effectiveness of Pulmonary Vein Isolation Plus Box Isolation of Fibrotic Areas With the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation
- Acronym
- GLOBAL-PF
- Condition
- Paroxysmal Atrial Fibrillation (PAF)
- Condition
- Persistent Atrial Fibrillation
- Intervention (Device)
- Globe Pulsed Field System
- Lead sponsor
- Kardium Inc.
Record details
- Record id
cardio:ct-nct06973031- Content hash
d502ab3188edf95032000f55d353340786918ebef3710362c6fb69ef8f6a8210